Author

A. Rubanov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. S. Shadaloey· 1 shared A. Chatterjee· 1 shared A. Garcia-Sastre· 1 shared A. I. Su· 1 shared A. Karz· 1 shared A. Rubens· 1 shared A. Tsirigos· 1 shared C. Benner· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. S. Shadaloey

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MetFinder: a neural network-based tool for automated quantitation of metastatic burden in histological sections from animal models

A. Karz, N. Coudray, E. Bayraktar, K. Galbraith, G. Jour, A. A. S. Shadaloey, N. Eskow, A. Rubanov, M. Navarro, R. Moubarak, G. Baptiste, G. Levinson, V. Mezzano, M. Alu, C. Loomis, , E. Hernando

MetFinder uses a deep neural network to automate metastasis burden quantification in histological sections from mouse models, improving throughput and resolution compared to current methods.

bioRxiv · Sep 7, 2023 · PreprintCancer Biology

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

L. Riva, S. Yuan, X. Yin, L. Martin-Sancho, N. Matsunaga, S. Burgstaller, L. Pache, P. De Jesus, M. V. Hull, M. Chang, J. F. W. Chan, J. Cao, V. Kwok-Man Poon, K. Herbert, T.-T. Nguyen, , S. Chanda

This study identifies 30 known drugs that inhibit SARS-CoV-2 replication, with six showing effective concentrations likely to be therapeutic in patients.

bioRxiv · Apr 16, 2020 · PreprintMicrobiology